A61K 38/206
Il-9
Official title: {il-9}
A61K38/206 (Il-9) appears on 15 US grants and 29 published applications in this corpus.
Search patents in A61K- Granted patents
- 15
- Published applications
- 29
- Assignees
- 17
- Inventors
- 52
- Latest grant
- 2 Aug 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 2 |
| 2016 | 1 | 0 |
| 2017 | 2 | 3 |
| 2018 | 4 | 1 |
| 2019 | 1 | 3 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 2 | 3 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modulating gamma-c-cytokine activity2 Aug 2022US 11,400,134 B2Bioniz, LLC
- Compositions for biological systems and methods for preparing and using the same28 Jun 2022US 11,369,640 B2SMART Surgical, Inc.
- Compositions for biological systems and methods for preparing and using the same29 Oct 2019US 10,456,423 B2SMART Surgical, Inc.
- Embryo implantation25 Dec 2018US 10,159,712 B2Ostara Biomedical Ltd.
- Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors16 Oct 2018US 10,098,927 B2Innomed, Inc.
- Il-9r signaling compositions and methods10 Sep 2026US 2026/0263516 A1The Regents of the University of California
- Modulation of pd-1 signaling for treatment of diseases30 Jul 2026US 2026/0216168 A1Wuhan University
- Combined delivery of antigens and tolerogenic signals via dual-sized hydrogel spheres and mof composites for type-1 diabetes vaccine development29 Jan 2026US 2026/0027192 A1The Hong Kong University of Science and Technology
- Methods and compositions to modulate riok218 Dec 2025US 2025/0381241 A1Dana-Farber Cancer Institute, Inc.
- Modulating gamma-c-cytokine activity2 Mar 2023US 2023/0060637 A1Bioniz, LLC
Most cited
By later US patents
- Porous objects having immobilized encapsulated biomolecules31US 8,709,464 B2The Regents of the University of Michigan · 2014
- Modulating gamma-C-cytokine activity9US 10,030,058 B2Bioniz, LLC · 2018
- Modulators of gamma-C-cytokine activity9US 10,030,059 B2Bioniz, LLC · 2018
- Method for treating cell mediated autoimmune disorders using interleukin-95US 5,830,454 ALudwig Institute for Cancer Research · 1998
- Modulating gamma-c-cytokine activity4US 11,400,134 B2Bioniz, LLC · 2022